Southern Hemisphere/Australia

The formulation of influenza vaccines for use in Australia is determined each year by the Australian Influenza Vaccine Committee based on information and recommendations from the World Health Organization (WHO).

Influenza Vaccine Composition 2012

Southern Hemisphere/Australia

The formulation of influenza vaccines for use in Australia is determined each year by the Australian Influenza Vaccine Committee (AIVC) based on information and recommendations from the World Health Organization (WHO). The AIVC met on 5 October 2011 and agreed to adopt the WHO recommendations.

The influenza vaccine for the Australian 2012 influenza season contains the following three virus strains:^{1, 2}

• A (H1N1): an A/California/7/2009 (H1N1) - like strain, 15 µg HA per dose
• A (H3N2): an A/Perth/16/2009 (H3N2) - like strain, 15 µg HA per dose
• B: a B/Brisbane/60/2008 - like strain, 15 µg HA per dose

References
1.    World Health Organization Recommended composition of influenza virus vaccines for use in the 2012 southern hemisphere influenza season Accessed at: WHO 2012 Southern Hemisphere recommendation

2.    Therapeutic Good Administration, Australian Influenza Vaccine Committee (AIVC) AIVC recommendations for the composition of influenza vaccine for 2012 to be advised. The 2011 recommendation can be accessed at:  TGA announcement